PCG
PBYI icon

Private Capital Group’s Puma Biotechnology PBYI Stock Holding History

Private Capital Group’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-51
Closed -$3K – 2403
2019
Q2 		$3K Buy
+51
New +$1.17K ﹤0.01% 1828
2018
Q3 		– Sell
-51
Closed -$3K – 2271
2018
Q2 		$3K Sell
51
-6
-11% -$348 ﹤0.01% 1813
2018
Q1 		$4K Sell
57
-2,202
-97% -$165K ﹤0.01% 1676
2017
Q4 		$12 Buy
+2,259
New +$253K ﹤0.01% 1283

Other funds holding PBYI

PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return